Strive Asset Management
Companies
Strive Asset Management is a US investment firm founded in 2022 by Vivek Ramaswamy and Anson Frericks, focused on shareholder capitalism and anti-ESG investing. In 2025, Strive launched Bitcoin-focused investment products and publicly advocated for corporate Bitcoin treasury adoption. The firm is a vocal supporter of Bitcoin as the hardest asset and opposes the use of ESG criteria that it believes disadvantage Bitcoin-related companies.
Details
- Ceo
- Matt Cole
- Status
- DUPLICATE
- Founders
- Vivek Ramaswamy,Anson Frericks
- Aum Approx
- $2B+
- Company Type
- Asset Manager / Investment Firm
- Founded Year
- 2022
- Headquarters
- Columbus, Ohio, USA
- Canonical Slug
- strive-inc
- Duplicate Note
- strive-asset-management is the pre-merger entity; strive-inc (Nasdaq: ASST) is the current public company after Jan 2026 Semler Scientific acquisition.
- Bitcoin Strategy
- Asset management firm co-founded by Vivek Ramaswamy focused on Bitcoin and energy companies. Manages Bitcoin equity ETF products and advocates for Bitcoin treasury adoption.
- Bitcoin Etf Products
- Yes
- Bitcoin Holdings Note
- Offers Bitcoin-focused ETF products. Proprietary treasury holdings not disclosed.
More Companies
Strategy (formerly MicroStrategy)
Strategy (Nasdaq: MSTR), formerly MicroStrategy, is the world's largest corporate Bitcoin holder. Founded by Michael Saylor, the company rebranded in 2025 to reflect its identity as a Bitcoin treasury company. It holds over 500,000 BTC accumulated through equity and debt financing, pioneering the corporate Bitcoin standard that inspired hundreds of companies worldwide.
ACINQ
ACINQ is a French Bitcoin infrastructure company and the developer of Eclair, one of the three major Lightning Network implementations. Founded in 2014, ACINQ builds Phoenix Wallet (a non-custodial Lightning wallet) and operates the ACINQ Lightning node, one of the most well-connected nodes on the Lightning Network.
Acurx Pharmaceuticals
Acurx Pharmaceuticals (NASDAQ: ACXP) is a US biopharmaceutical company that made headlines in November 2021 by adopting Bitcoin as its primary treasury reserve asset — one of the first pharmaceutical companies to do so. The company approved purchasing $1 million in Bitcoin and has continued to hold BTC alongside its drug development pipeline focused on antibiotics. Notable for crossing industry boundaries to embrace the Bitcoin standard.
Reviews
No reviews yet. Be the first to share your experience!
Free Beginners Guide to Buying Bitcoin
New to Bitcoin? Get our complete beginner's guide.